Nurix Therapeutics Ownership | Who Owns Nurix Therapeutics?
Nurix Therapeutics Ownership Summary
Nurix Therapeutics is owned by 101.23% institutional investors, 1.41% insiders. Fmr is the largest institutional shareholder, holding 14.61% of NRIX shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 3.23% of its assets in Nurix Therapeutics shares.
NRIX Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Nurix Therapeutics | 101.23% | 1.41% | -2.64% |
| Sector | Healthcare Stocks | 279.42% | 10.64% | -190.05% |
| Industry | Biotech Stocks | 64.05% | 10.69% | 25.27% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Fmr | 10.63M | 14.61% | $200.35M |
| Blackrock | 6.82M | 12.42% | $142.33M |
| Blackrock funding, inc. /de | 7.68M | 10.55% | $144.61M |
| Vanguard group | 4.35M | 5.97% | $81.86M |
| Redmile group | 4.19M | 5.76% | $78.99M |
| Baker bros. advisors lp | 3.88M | 5.33% | $73.14M |
| State street | 2.71M | 4.93% | $56.53M |
| Wellington management group llp | 3.59M | 4.93% | $67.57M |
| Price t rowe associates inc /md/ | 3.01M | 4.13% | $56.66M |
| Commodore capital lp | 3.00M | 4.12% | $56.52M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Redmile group | 4.19M | 5.50% | $78.99M |
| Commodore capital lp | 3.00M | 4.14% | $56.52M |
| Soleus capital management | 2.10M | 2.49% | $39.62M |
| Affinity asset advisors | 940.08K | 2.37% | $17.71M |
| Deep track capital, lp | 3.00M | 2.11% | $56.52M |
| Parkman healthcare partners | 532.17K | 1.34% | $10.03M |
| Westhill financial advisors | 228.33K | 0.96% | $4.30M |
| Vienna powszechne towarzystwo emerytalne s.a. vienna insurance group | 85.00K | 0.93% | $1.60M |
| Baker bros. advisors lp | 3.88M | 0.78% | $73.14M |
| Rhenman & partners asset management ab | 290.00K | 0.56% | $5.46M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Fmr | 10.63M | 0.01% | 10.05M |
| Blackrock | 6.82M | 0.00% | 2.24M |
| Commodore capital lp | 3.00M | 4.14% | 1.35M |
| Soleus capital management | 2.10M | 2.49% | 1.04M |
| Point72 asset management | 872.96K | 0.04% | 872.96K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Ra capital management | - | - | -1.33M |
| Bain capital life sciences investors | - | - | -1.13M |
| Deep track capital, lp | 3.00M | 2.11% | -868.10K |
| Driehaus capital management | - | - | -715.94K |
| Ark investment management | 1.53M | 0.24% | -686.07K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Point72 asset management | 872.96K | 0.04% | 872.96K | $16.45M |
| Perceptive advisors | 330.61K | 0.17% | 330.61K | $6.23M |
| Norges bank | 318.80K | 0.00% | 318.80K | $6.01M |
| Integral health asset management | 150.00K | 0.30% | 150.00K | $3.13M |
| Strs ohio | 28.70K | 0.00% | 28.70K | $598.97K |
Sold Out
| Holder | Change |
|---|---|
| True wealth design | -4.00 |
| Ifp advisors | -6.00 |
| Nelson, van denburg & campbell wealth management group | -9.00 |
| Farther finance advisors | -14.00 |
| Federated hermes | -15.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2025 | 171 | -3.93% | 84,588,676 | 4.29% | 101 | 0.69% | 93 | -11.43% | 51 | 10.87% |
| Dec 31, 2024 | 177 | 1.72% | 81,111,271 | 20.04% | 120 | 1.40% | 103 | 9.57% | 47 | -16.07% |
| Sep 30, 2024 | 174 | -1.14% | 67,568,477 | 3.95% | 92 | 0.66% | 94 | -16.81% | 56 | 24.44% |
| Jun 30, 2024 | 175 | 24.11% | 64,997,079 | 32.92% | 118 | 1.49% | 112 | 60.00% | 45 | 4.65% |
| Mar 31, 2024 | 141 | 6.82% | 48,899,624 | 6.46% | 89 | 1.25% | 70 | 2.94% | 43 | 10.26% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 2.47M | 3.23% | - |
| Vanguard US Total Market Shares ETF | 2.13M | 2.79% | 196.50K |
| iShares Russell 2000 ETF | 1.78M | 2.33% | -33.81K |
| Fidelity Select Health Care | 1.60M | 2.09% | - |
| ARK Genomic Revolution | 1.56M | 2.05% | 53.95K |
| ARK Genomic Revolution ETF | 1.52M | 1.99% | -9.12K |
| US Small-Cap Growth II Equity Comp | 1.35M | 1.76% | 14.21K |
| T. Rowe Price New Horizons | 1.35M | 1.76% | -6.71K |
| Nikko AM ARK Pstv Chg Innovt P JPY Acc | 1.10M | 1.44% | 273.18K |
| Vanguard Institutional Extnd Mkt Idx Tr | 1.09M | 1.43% | -37.02K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Aug 01, 2025 | van Houte Hans | Chief Financial Officer | Sell | $59.60K |
| Jul 30, 2025 | van Houte Hans | Chief Financial Officer | Sell | $51.70K |
| Jul 30, 2025 | Ring Christine | Chief Legal Officer | Sell | $46.13K |
| Jul 30, 2025 | Hansen Gwenn | Chief Scientific Officer | Sell | $51.74K |
| May 02, 2025 | van Houte Hans | Chief Financial Officer | Sell | $70.24K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q3 | - | 4 |
| 2025 Q2 | - | 4 |
| 2025 Q1 | - | 11 |
| 2024 Q4 | - | 10 |
| 2024 Q3 | - | 13 |
NRIX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools